The Raise Finally Exceeds the Beat: Trane Converts the Backlog and De-Rates Anyway

Results vs. Consensus

Q2 2026 Scorecard

Year-Over-Year Comparison

Sequential Comparison

The sequential step is the part of this print that answers the Q1 question directly. Trane's second quarter is seasonally its strongest, so a sequential improvement is expected; the magnitude is not.

Revenue. Organic revenue of 9% against a guide of roughly 5% is the single most consequential number in the release, because it is the first direct evidence that the record order book converts. We wrote in April that backlog conversion, not order intake, was the variable that mattered, and this quarter converted. Applied revenue growing more than 40% is the mechanism: applied is the high-content, long-lead equipment where the bookings surge has been concentrated, and it is now showing up in shipments rather than in backlog. Americas organic revenue of 11% carried the enterprise, Asia Pacific added 10%, and EMEA subtracted 4%. The composition matters as much as the level. This was not a price-driven quarter dressed up as volume; it was equipment leaving factories.

Margins. Gross margin at 35.6% is the weakest line in the report and the one that failed its own signpost. We said in April that we would grade Q2 on whether the gross margin decline narrowed from 100bps. It widened to 203bps. Cost of goods sold grew 14.2% while revenue grew 10.6%, and there are three identifiable contributors, none of which management sized individually: price still running behind inflation, capacity and operating-system investments flowing through the P&L as production ramps, and a mix shift toward first-year acquisition revenue that carries a lower initial margin. The offset is real: SG&A grew only 3.9% on 10.6% revenue growth, producing 104bps of operating leverage that halved the gross margin damage before it reached the operating line. That is a genuine cost-discipline result, and it is why the GAAP operating margin fell 100bps rather than 200, with a roughly 40bp year-over-year swing in non-GAAP add-backs taking the adjusted decline to 60bps. But an operating margin defended by SG&A restraint rather than by gross profit is a lower-quality margin, and it is the reason we treat Q3's guided 50bps of expansion as the falsifiable test of this upgrade rather than a formality.

EPS. Adjusted EPS of $4.31 cleared the high end of the company's own $4.20 to $4.25 guide by $0.06 and the Street by $0.05, extending a beat streak that now runs seventeen consecutive quarters on a consistent vendor basis. The composition is worth stating plainly because it tempers the headline: 11.1% adjusted EPS growth against 7.4% adjusted operating income growth means roughly a quarter of the increase came from tax rate, buyback and interest rather than from the business. None of those three is illegitimate, and all three are recurring rather than one-time (the buyback is a standing program, the tax rate is a structural Irish-domicile advantage, and the debt stack is unchanged at $4,616.8M). But an investor underwriting 2027 on this quarter's earnings algorithm should model a 7% operating growth engine with a 3- to 4-point below-the-line uplift, not an 11% operating engine.

Bookings, Backlog and Book-to-Bill

Three facts in this table did not exist in April. First, EMEA organic bookings returned to growth at 4%, from a 9% decline in Q1, which was the second of our four named Q2 signposts and is the difference between a regional problem and a portfolio problem. Second, the book-to-bill exceeded 100% in every segment, not just in the Americas, so the order book is no longer a single-region phenomenon. Third, management put a number on how much of the backlog is beyond the guide year: roughly $6 billion of the $12.1 billion is scheduled for 2027 and later. That is the disclosure whose absence we criticized in April, and it reframes the debate. Half of the backlog is not a 2026 event, which is exactly what the bears argued. But the other half is, and 2026 revenue is now guided to grow 11.5%.

The composition of the backlog is roughly 90% to 95% commercial HVAC, with the Americas commercial HVAC backlog up approximately 90% year over year and its book-to-bill running near 135%. Concentration of that degree is a genuine risk and we treat it as one below. It is also, mechanically, what a company looks like when one product line is winning a capital cycle.

Cash Flow and Balance Sheet

Free cash flow of $1,602.7M for the half nearly doubled and converted at 104% of adjusted continuing earnings attributable to shareholders, comfortably clearing the full-year commitment. The mechanism deserves scrutiny, because a cash flow that improves by $761M while revenue grows 8.5% is not a normal operating outcome. Working capital as a percentage of revenue fell 280bps to 0.9%, and the balance sheet shows why: accrued expenses and other current liabilities rose $1,281.9M in six months, to $4,721.7M from $3,439.8M. That is a 37% increase in a liability line whose composition the earnings exhibit does not disclose, in the same six months that the backlog grew by roughly $4 billion. Customer advances on large applied and modular projects are the obvious candidate, and if so the cash flow strength is a direct byproduct of the order book rather than an efficiency gain. That is a good thing, but it is a different thing, and it will reverse as those projects ship.

The receivables line points the same direction. Net receivables grew 17.4% year over year against revenue growth of 10.6%, and days sales outstanding rose to 60.8 from 57.3. Inventory grew 10.8% with turns roughly flat at 6.3. Payables grew 17.7% with days payable outstanding up two days to 66.3. Read together: the company is carrying more receivables and more inventory to support the ramp, and is funding both with payables and with what appear to be customer advances. Capital expenditure of $156.1M ran at 1.4% of revenue for the half against a 2% to 3% full-year guide, which implies a substantial second-half step-up in spending that is not yet in the cash flow.

Segment Performance

The revenue mix shifted toward the Americas again, to roughly 83% of the enterprise from 80% in Q1, with EMEA at 11% and Asia Pacific at 6%. Every segment's margin declined year over year, which is the honest summary of the quarter's profitability: this was a volume and orders quarter, not a margin quarter, in all three regions.

Americas (83% of revenue)

The Americas produced organic revenue growth of 11% and organic bookings growth of 43%, on a revenue base that is now larger than the other two segments combined by a factor of nearly five. Commercial HVAC bookings reached an all-time high, up 50%, with applied bookings up 130% in what is now the fourth consecutive quarter of applied growth above 100%. On a two-year stack, applied bookings are up more than four times. The revenue side finally caught up: applied revenue grew more than 40%, and management guided that rate to persist through the second half.

"Second quarter results were strong, led by standout performance in Americas. Commercial HVAC delivered exceptional bookings up 50% and organic revenue up low teens. Our residential business exceeded our expectations for the quarter, with bookings up high 20s and organic revenue up low teens." — David Regnery, Chair and CEO

Segment adjusted operating margin fell 30bps to 22.1%, which is the mildest of the three regional declines and, given the size of the volume ramp, a reasonable outcome. The pressure is investment, not pricing collapse: management described capacity expansion, innovation spending and channel expansion as the drivers, with a further drag from deploying its operating system into recently acquired businesses. The chief operating officer disclosed that the quarter contained four orders above $100 million, one of them at Stellar Energy. Order concentration of that size is new information about the shape of the book and cuts both ways: it explains the growth rate and it means a single deferral is now material to a quarter.

Assessment: This is the segment that carries the equity story and it delivered on both sides of the equation for the first time in this cycle. Bookings at 43% organic with revenue at 11% organic still means the backlog is building faster than it converts, which extends the runway rather than closing it. The 30bp margin decline is the acceptable price of a 4x capacity expansion; a second quarter of it without the guided Q3 recovery would not be.

EMEA (11% of revenue)

EMEA is where the quarter's damage sits. Revenue fell 1.5% reported and 4% organic, and GAAP operating margin collapsed 550bps to 11.8%, with the adjusted figure down 420bps to 13.1%. The cause is specific and quantified: the Middle East, which represents less than 3% of enterprise revenue but roughly 15% of the EMEA segment, saw revenue fall about 30% in the quarter, and management has guided it down about 30% again through the second half. Excluding the Middle East, the segment's bookings rose mid-teens and revenue rose low single digits; within commercial HVAC specifically, ex-Middle East bookings rose more than 20% and revenue rose mid-single digits.

"In EMEA, margins were impacted by the conflict in the Middle East. As the regional outlook became clearer during the quarter, we acted to align our cost structure for improved profitability in the second half." — Christopher Kuehn, EVP and CFO

Cost actions were taken at the end of June, covering both headcount and infrastructure. The CFO framed the effect precisely: deleverage in Q2 ran above gross margins, and after the actions is expected to run within gross margins in the second half. The company sized the full second-half EMEA headwind at roughly $100 million of revenue and $30 million of operating income, about $0.10 of adjusted EPS, and absorbed all of it inside a guide it still raised by $0.40.

Assessment: The important development is not the margin, it is the bookings. EMEA organic bookings went from minus 9% in Q1 to plus 4% here, and management described a European pipeline that has begun to inflect after a long flat stretch. A segment with a quantified, exogenous, cost-actioned revenue hole and an improving order book is a contained problem. We would revisit that judgment if the second-half deleverage does not stay within gross margins as promised, or if the ex-Middle East order momentum stalls.

Asia Pacific (6% of revenue)

Asia Pacific grew organic revenue 10% and organic bookings 31%, the second-best bookings growth rate in the portfolio. Adjusted operating margin fell 60bps to 21.0% and adjusted EBITDA margin fell 150bps to 21.8%, declines that on a $385M revenue base are small in dollars and noisy in percentage terms. Management characterized the growth as concentrated outside China, and is adding account managers in India, Malaysia and Thailand.

"On Asia, look, China still remains dynamic, but the rest of Asia is where we're seeing growth. In fact, -- that's where we're also doubling down on some of our investments, especially on the channel side, and that would be adding account managers because we see a lot of opportunities in India, for example, in Malaysia, Thailand." — David Regnery, Chair and CEO

Assessment: A 31% organic bookings quarter in the smallest segment is a useful confirmation that the demand signal is not a single-region artifact, and the deliberate channel build in South and Southeast Asia is the right use of an up-cycle. The margin decline is not yet meaningful at this revenue scale. Asia Pacific will not move the enterprise in 2026; it is the segment to watch for evidence that the applied franchise travels.

Key Topics & Management Commentary

Overall Management Tone: Management was confident and, for the first time in the recent record, willing to put that confidence into the guidance rather than into adjectives. Where the Q1 call paired triumphant demand language with an unchanged nine-month outlook, this call raised the outlook twice over and volunteered the second-half Middle East headwind it was absorbing. The one place the posture turned defensive was operating leverage, where the answer arrived pre-empted and framework-level ahead of the question rather than in response to it.

1. The Raise Finally Exceeds the Beat

The defining fact of the April quarter was that the full-year adjusted EPS guide was raised by exactly $0.10, precisely the size of the Q1 beat, which meant the remaining nine months were untouched. This quarter reverses that completely. The guide moved to $15.20 to $15.30 from $14.75 to $14.95, a $0.45 raise at the low end and $0.35 at the high end, against a beat of $0.05 versus consensus and $0.06 versus the company's own guide. The organic revenue guide moved from approximately 7% to approximately 9%, and the reported revenue guide from approximately 9.5% to approximately 11.5%.

"For the full year, we are again raising our guidance. This reflects the market dynamics and investment priorities we've discussed and consistent strong execution of our value creation flywheel. We are increasing our full year organic revenue growth outlook to approximately 9% and our adjusted EPS guidance to a range of $15.20 to $15.30." — Christopher Kuehn, EVP and CFO

The arithmetic of what that implies is demanding. Half-year adjusted EPS of $6.94 against a $15.25 midpoint leaves $8.31 for the second half. With Q3 guided to approximately $4.70, the implied fourth quarter is roughly $3.61 against $2.86 a year ago, a 26% increase. The implied Q3 growth rate is 21%. Both are roughly double the 11% the company just delivered.

Assessment: A raise eight times the size of the beat is the strongest signal in the release and it is the specific thing we said in April would change our view. It is also a guide that now carries real execution risk, because management has moved the burden of proof from the order book to the factory floor. The company chose that trade deliberately, and it did so with $12.1 billion of backlog behind it.

2. Backlog at $12.1 Billion and What Converts When

Backlog reached $12.1 billion, up 70% year over year, on bookings of $7,818M and a 123% book-to-bill. The number that was missing in April is now disclosed: roughly $6 billion is scheduled for 2027 and beyond, meaning approximately half of the backlog sits outside the guide year.

"Our exceptional bookings, record backlog and healthy pipeline provides strong visibility to accelerating revenue in the second half. Our historic backlog also lays a strong foundation for continued market outperformance in the future. with approximately $6 billion slated for 2027 and beyond." — David Regnery, Chair and CEO

On conversion mechanics, management was more forthcoming than it has been. Applied revenue grew more than 40% in the quarter and the guide assumes that rate carries through the second half. Backlog composition is roughly 90% to 95% commercial HVAC, with the Americas commercial HVAC backlog up approximately 90%.

Assessment: Disclosing the 2027 split converts the biggest open question of the April print into a quantified fact, and the answer is roughly the one the bears assumed. That is a good outcome for the equity, because it removes an unknown rather than confirming a fear: $6 billion inside the guide year at a 40% applied conversion rate is what the raised guide is built on, and $6 billion outside it is the 2027 foundation. The residual risk is not the size of the backlog but its concentration, since 90%-plus in one product family means a single vertical's pause is the whole story.

3. Americas Commercial HVAC and the Fourth Straight 100%-Plus Applied Quarter

Americas commercial HVAC bookings reached an all-time high, up 50%. Applied bookings rose 130%, the fourth consecutive quarter above 100%, and the two-year stack is up more than four times. Americas commercial HVAC book-to-bill ran near 135%.

"Our commercial HVAC businesses delivered outstanding performance, particularly in the Americas, where bookings reached an all-time high up 50% year-over-year. Applied bookings were up 130%, marking our fourth consecutive quarter of growth above 100%. On a 2-year stack, applied bookings are up more than 4x." — David Regnery, Chair and CEO

The pipeline question drew the most emphatic answer of the call. Management said the pipeline it described two or three quarters ago as the strongest it had ever seen remains "really, really strong," and added that the European pipeline has begun to increase after a long flat stretch.

Assessment: Four consecutive quarters above 100% applied bookings growth, against a two-year stack up more than four times, is no longer a comparison artifact. It is a share and capital-cycle result. The bull pillar we established in April is not merely intact, it has strengthened, and the addition of an inflecting European pipeline widens it beyond the single region that carried it in Q1.

4. Gross Margin: The One Line That Went the Wrong Way

Gross margin fell 203bps to 35.6%, a wider decline than the 100bps recorded in Q1. Cost of goods sold grew 14.2% against revenue growth of 10.6%. Management never addressed gross margin as a line, discussing profitability instead at the operating and EBITDA levels where the declines are 60bps and 70bps respectively. On price versus cost, the CFO was direct about the direction if not the magnitude: it was a headwind in Q2 as expected, it will remain a headwind in the second half, and it improves sequentially from Q2 into Q3 and again into Q4.

"Margins in the Americas and Asia remain healthy and reflect increased investments in capacity, innovation and channel expansion to support robust demand." — Christopher Kuehn, EVP and CFO

The framing is worth noting for what it does not include. Capacity, innovation and channel expansion are operating expenses in most industrial P&Ls; the fact that the pressure showed up in cost of goods sold rather than in SG&A (which grew only 3.9%) suggests the drag is production-side: absorption on ramping lines, first-year cost structures at acquired plants, and unrecovered input inflation on a backlog quoted months ago.

Assessment: This is the failed signpost, and we will not soften it. We said in April that we would grade Q2 on whether the gross margin decline narrowed from 100bps, and it doubled instead. The mitigating facts are that SG&A leverage absorbed half of it, that the GAAP operating margin decline actually narrowed from Q1, and that management has now committed to a specific reversal in Q3. The mitigating facts do not change what the line says: two consecutive quarters of widening gross margin decline in a company guiding to full-year margin expansion.

5. Operating Leverage Below the Committed Rate

In April management committed to organic operating leverage improving to the mid-twenties in Q2 from the high teens in Q1, on a standing long-term target of 25% or better. The quarter did not deliver it. Adjusted operating income grew $86.5M on $607.1M of revenue growth, a reported incremental margin of 14.2%. Management reaffirmed the 25%-plus full-year target and disclosed a roughly 700bp gap between reported and organic leverage, driven by acquisitions and first-year investments, which puts organic leverage in the low twenties: better than reported, still short of the commitment.

"Yes. Amit, I'd add some of these investments are captured in CapEx. Some of these investments are just flowing through the P&L as you think about ramping up production and bringing our business operating system to line. So that's 1 of the impacts on leverage here in the second quarter, it may impact leverage in the very near term." — Christopher Kuehn, EVP and CFO

The CEO pre-empted the criticism before it was pressed, telling the call not to be distracted by any single quarter and that a quarter below target was acceptable given the growth being created. The CFO separately noted that Q2 2025 carried organic leverage near 40%, making the comparison unusually hard.

Assessment: The tough comparison is real and the investment explanation is credible, particularly with a 4x applied capacity expansion under way. Missing a leverage commitment made ninety days earlier is nonetheless a miss, and the pre-emptive framing is a tell that management knew it. The check is mechanical: the full-year 25%-plus target survives only if the second half runs well above it, which is the same second-half dependency that governs the margin guide and the revenue guide.

6. EMEA and the Middle East: Quantified and Cost-Actioned

The Middle East is less than 3% of enterprise revenue and roughly 15% of the EMEA segment. Its revenue fell about 30% in Q2 and is guided down about 30% again in the second half. The company sized the second-half impact at roughly $100 million of revenue and $30 million of operating income, about $0.10 of adjusted EPS, and absorbed it within the raised guide. Cost actions covering headcount and infrastructure were completed at the end of June.

"But -- just given the ongoing conflict and the performance in the second quarter, we did take some cost actions at the end of June. This would include looking at rightsizing for positions and also for infrastructure -- that's behind us at this point, confident that the deleverage was above gross margins in the second quarter after those cost actions, we do expect deleverage to be within gross margins into the second half of the year." — Christopher Kuehn, EVP and CFO

Excluding the Middle East, EMEA bookings rose mid-teens and revenue rose low single digits, with commercial HVAC bookings up more than 20%.

Assessment: This is the model of how to handle a regional shock: size it, act on the cost base inside the quarter, absorb it in the guide, and disclose the ex-item performance so investors can separate the exogenous from the structural. Sizing the drag also removes the ambiguity we flagged in April, when the EMEA bookings decline received no dedicated explanation. The remaining question is duration, which management cannot answer and did not pretend to.

7. Residential: A Second Consecutive Upward Revision

Residential bookings rose high twenties and organic revenue rose low teens, well ahead of the flattish Q2 management had guided in April. The full-year outlook has now been revised upward twice, taking it through three guide levels in seven months: down roughly 5% in the January plan, roughly flat in April, mid-single-digit growth now.

"Our residential business exceeded our expectations for the quarter, with bookings up high 20s and organic revenue up low teens." — David Regnery, Chair and CEO

Channel inventory, which was the source of the fourth-quarter 2025 disruption when the company removed 30% of production days to correct it, is clean for a third consecutive quarter.

"I would add, Scott. I mean, year-to-date sell-in is really approximately equal to sell-through. And to Dave's point, inventory is at a good spot at the end of the quarter." — Christopher Kuehn, EVP and CFO

Assessment: Residential has gone from a drag management was managing down to a contributor management is raising, with a clean channel behind it and easier comparisons ahead. This is the most improved part of the portfolio relative to the January starting point, and it materially weakens the narrow-growth bear case we scored Confirmed in April. It is also the part of the business most exposed to a consumer slowdown, and two consecutive raises set a higher bar for the third.

8. Data Centers: Broad-Based Growth, Still Unsized

Management again declined to size the data center vertical, and again pushed back on the idea that it is the whole story. All fourteen tracked verticals grew orders more than 20% in the quarter, and on a year-to-date basis eleven of fourteen grew orders, most of them at double-digit rates. Both are bookings statistics, not revenue.

"But it's probably more constructive to look year-to-date -- and year-to-date, we had growth in 11 of 14 verticals from an order standpoint. And most of those 11 were double-digit growth. So Andy, as we've spoken before, we're very strong in the data center vertical. We've been very strong for a long time and will be very strong in the future. But the growth that we're seeing right now is very broad-based, which plays to our strength with the strength of our leading portfolio." — David Regnery, Chair and CEO

On technology, management described a mix shifting toward air-cooled and closed-loop designs, less evaporative cooling, and chillers that increasingly carry embedded control intelligence to optimize leaving-water temperature across free-cooling and vapor-compression modes. The company runs joint design days with hyperscale and colocation customers covering the full thermal loop rather than the chiller alone, and reports that several hyperscalers now operate under master purchase agreements or long-term capacity commitments. The coolant distribution unit business acquired with Liquid Stack is described as exceeding expectations.

Assessment: The breadth disclosure is the most useful thing management said on this topic, and it is the first quantitative rebuttal to the concentration fear rather than a rhetorical one. Fourteen of fourteen verticals above 20% on orders cannot be a data center story alone. The refusal to size the vertical remains a legitimate reason to withhold a re-rating premium, but it is now paired with evidence that the growth does not depend on it.

9. Stellar Energy: Revenue On Track, Accretion Withdrawn

Stellar remains on track for approximately $500 million of 2026 revenue, roughly half of the $1 billion backlog acquired with it. The earnings contribution has been revised down.

"I think I told you all at the end of last quarter that we thought Stellar would be modestly accretive for the year. I think you should look at and what we have modeled into our guide is stellar being flat for the year from an EPS standpoint." — David Regnery, Chair and CEO

The stated cause is pulled-forward investment to deploy the business operating system. One of the four orders above $100 million booked in the quarter was at Stellar.

Assessment: A downgrade from modestly accretive to flat is small in dollars and was volunteered rather than extracted, which is the right way to handle it. It is also the second data point this quarter, alongside the gross margin line, indicating that first-year integration costs are running hotter than planned. Two small negatives pointing the same direction are worth tracking as one.

10. Transport Refrigeration: The Turn Management Now Underwrites

After an extended trough, management now expects the Americas transport market to improve in late 2026 and lead into a multi-year up cycle, with an internal view directionally aligned to third-party forecasts but assuming a more gradual slope on the reasoning that trailer original-equipment manufacturers will take time to ramp capacity, which historically extends cycle duration.

"Look, rejection rates have remained high for several months. That's a key indicator. Spot to contract spread is trending positively for several months, and utilization rates have trended positive for the last 10 months. So these are all good signs for our Thermo King business." — David Regnery, Chair and CEO

Assessment: Three independent freight indicators trending the same direction for multiple months is a more disciplined case than the market-has-not-turned framing of April, and the deliberately shallower slope assumption is the credible version of the call. Transport moving from headwind to contributor is unmodelled optionality for 2027 in a story that is otherwise entirely about commercial HVAC. The company did not quantify Q2 transport revenue, so the turn remains asserted rather than evidenced in the reported numbers.

11. Capital Allocation: M&A Ahead of Buyback

Capital deployment remains targeted at $2.8 billion to $3.3 billion for the year, with roughly $1.9 billion deployed or committed year to date through July. The dividend was raised 12% earlier in the year to $4.20 per share annualized.

"In addition to dividends, we have repurchased approximately $840 million of shares year-to-date with $3.8 billion remaining on our current share repurchase authorization. We continue to pursue disciplined M&A and are strategically investing in capacity to support future growth. with expected CapEx of 2% to 3% of revenue in 2026." — Christopher Kuehn, EVP and CFO

The cash flow statement puts settled repurchases at $756.4M for the six months to June 30, against $879.6M in the prior-year half, a 14% reduction. Acquisitions went the other way, to $742.0M from $277.2M. Management describes repurchasing shares "when the stock trades below our calculated intrinsic value", which makes the buyback pace a disclosed opinion about valuation.

Assessment: Capital has rotated from buyback toward M&A while the stock traded near its highs, which is internally consistent with the stated policy and reads as discipline rather than as a signal. The more interesting implication is forward-looking: with the shares now 12.5% below the 52-week closing high, the same policy implies a faster repurchase pace in the second half if management's intrinsic value estimate has not moved down. We would treat a visible Q3 buyback acceleration as management's own vote on this print.

Guidance & Outlook

The shape of the raise matters more than its size. Management did not simply add the beat to the year; it lifted the organic revenue assumption by two full points and the EPS midpoint by $0.40, while separately absorbing a newly quantified $0.10 second-half EMEA headwind. Netting that headwind out, the underlying operational raise is closer to $0.50. The company also introduced a GAAP EPS range for the first time in this cycle at $15.00 to $15.10, sitting $0.20 below the adjusted range, which brackets full-year non-GAAP adjustments at roughly $45 million after tax.

Implied second-half ramp. Half-year adjusted EPS of $6.94 against a full-year midpoint of $15.25 leaves $8.31 for the second half. Q3 is guided to approximately $4.70, so the implied fourth quarter is roughly $3.61 against $2.86 in Q4 2025, an increase of about 26%. Q3's guide implies 21% growth against $3.88. The company just grew adjusted EPS 11%. On revenue, an approximately 11.5% full-year reported growth rate on the FY2025 base of $21,321.9M implies roughly $23,774M, which against half-year revenue of $11,322.9M requires second-half reported growth near 14.4%. On the organic line the arithmetic is tighter: half-year organic growth was approximately 6.3%, so an approximately 9% full-year figure requires roughly 11.6% in the second half, and with Q3 guided to approximately 10%, the implied fourth quarter is roughly 13%. The highest organic growth rate of the year is required in its final quarter.

Implied margin ramp. Adjusted operating margin fell 40bps in the first half, to 18.1% from 18.5%. Management guided Q3 to roughly 50bps of expansion and Q4 to more than a full point, led by the Americas, with EMEA under continued pressure and Asia Pacific too small to matter to the enterprise line. The entire full-year margin story therefore sits in the second half, and specifically in a fourth quarter that must also deliver the year's highest organic growth rate.

Street at: The pre-print full-year consensus sat near $14.91. The new $15.25 midpoint clears it by roughly $0.34, so the raise is a genuine reset of the earnings base rather than a catch-up to where the Street already was.

Guidance style: Trane has beaten the vendor consensus in seventeen consecutive quarters and has historically set guides it clears. That pattern argues the $15.30 high end is more probable than the $15.20 low end. It argues less comfortably here than usual, because this is the first guide in the recent record that management raised well beyond the quarter it just delivered, which removes some of the conservatism cushion that made the streak possible.

Analyst Q&A Highlights

Whether Capacity Constraints Will Force the Company to Turn Away Orders

The dominant line of questioning on the call was whether the order book has reached a physical ceiling. With backlog now roughly half of a full year's revenue and concentrated in applied equipment, which is a minority of total revenue, the implied lead times and factory loading raised the question of whether Trane can still say yes to incremental demand. Management rejected the framing outright, pointing to a fourfold applied capacity expansion over three years that is still under way, ongoing brick-and-mortar investment at Grand Rapids and Stellar, and lean-driven throughput gains inside the existing footprint. The follow-up made the underlying anxiety explicit: successive order levels once described as peaks have been exceeded repeatedly.

Q: "So just given there's no material elongation of the backlog, I guess it kind of begs the question, at what point do you start turning away orders because of any capacity constraints."
— Amit Mehrotra, UBS

A: "We're not turning away orders, okay? We kind of I think I mentioned probably 2 quarters ago, we've expanded our applied capacity 4x over the last 3 years. That expansion continues to happen."
— David Regnery, Chair and CEO

Assessment: The answer is direct and checkable, and the capacity investment behind it is visible in the capital expenditure guide and in the gross margin. What the exchange did not resolve is the peak question, which no company can answer about its own order book. The useful takeaway is that the constraint on 2027 revenue is unlikely to be Trane's ability to build.

Backlog Conversion Versus Prior Cycles

A closely related line probed whether the composition of the backlog has changed its conversion characteristics, on the reasoning that a shift toward data center work might carry longer cycle times than the historical mix. Management answered with the one statistic that settles it for the current year, and then extended it into a forward commitment covering the second half.

Q: "I guess the question is, has there been any change in the conversion of backlog versus a year or 2 ago, just backlog is built. I imagine every -- you guys are mixing to data center, which may be a slower conversion."
— Christopher Snyder, Morgan Stanley

A: "On the conversion, if you look at our revenue growth in the second quarter for Applied, it was up over 40%. And -- so you can see the backlog is starting to flow through. And if you look at the back half of the year, based on our current guide, we're projecting that 40% to carry forward to the back half of the year."
— David Regnery, Chair and CEO

Assessment: This is the most valuable exchange on the call. It converts an abstraction into a rate, and it commits management publicly to sustaining that rate for two more quarters. Applied revenue growth is now the single cleanest metric on which to grade the second half, and management chose to be graded on it.

Whether Incremental Margins Improve From Here

A recurring line of questioning pressed on whether the cost pressure moderates as new capacity scales, and specifically whether incremental margins recover. The response confirmed the direction while conceding that price versus inflation stays negative through the year, and located the recovery in a sequential improvement rather than an immediate one.

Q: "But did the cost issues kind of mitigate over time and thinking in terms of scaling in particular on new capacity, but -- would we -- I guess a better way to ask the question is should we expect a little bit of improvement in incremental margins kind of going forward?"
— Scott Davis, Melius Research

A: "Yes. That's how we got the guide slated for this year, margins are stronger in the second half and comps do matter. In the second quarter last year, we had organic leverage up around 40%. So you're right, it does get better in the second half. I mean, price versus all inflation. It was a headwind in the second quarter as we thought. We're having our guide, it will be a bit of a headwind in the second half of the year as well."
— Christopher Kuehn, EVP and CFO

Assessment: The admission that price versus inflation remains a headwind through the second half is the most important qualifier attached to the raised guide. It means the guided margin expansion has to come from volume absorption, mix and cost actions rather than from pricing catching cost, which is a harder path and a slower one. The tough prior-year comparison is a fair defense of Q2 and not of the full year.

The Shape of Margin Expansion by Segment in the Second Half

The most specific forward commitment of the call came in response to a question on how the guided margin recovery distributes across the three segments given the continuing EMEA drag. Management put numbers on both quarters and named where the expansion originates.

Q: "I think, although correct me if I'm wrong, that 3Q is implied to be back to year-over-year margin expansion. Maybe you can talk directionally about where we should see margin expansion across the segments because obviously, with EMEA, there's a tough comp there with Middle East continuing."
— Noah Kaye, Oppenheimer

A: "Noah, I'd say you're right on the guidance that we put out that we have a lot of confidence in we would expect margin expansion in the third quarter. It's probably in that 50-ish basis point kind of range. And then it accelerates into the fourth quarter, which should be -- we'd be targeting over 1 point of margin expansion."
— Christopher Kuehn, EVP and CFO

Assessment: A named basis-point figure for a specific future quarter is the most falsifiable thing management said, and it is the test we will grade this upgrade against. Fifty basis points in Q3, from a company that has just posted two consecutive quarters of gross margin decline, requires the price-cost lag to stop widening within one quarter.

Whether the Reinvestment Drag Persists Into Next Year

One line of questioning attempted to establish whether the Americas reinvestment that suppressed leverage this quarter is a Q2 event or a run-rate that carries into the first half of 2027. The response weighted the components but declined to bound the duration, and the chief executive then addressed the leverage shortfall directly and without prompting.

Q: "I wondered if you could talk just a little bit about the impact from business reinvestments in the Americas. I wonder if you can maybe give us a sense of the weighting of those 3 points. And whether or not it's something we need to think about as we think about the first half of next year as well."
— Alexander Virgo, Evercore ISI

A: "But look, don't get held off by any 1 quarter. We've been saying for a while, our our target is 25% plus. We may have a quarter like the second quarter, we were below that, but that's okay, right? This is all about long-term growth that we're creating."
— David Regnery, Chair and CEO

Assessment: This is a management team acknowledging a missed commitment in the same breath as reaffirming the target it missed. The framing is defensible on a multi-year view and evasive on the twelve-month one, since the question asked about the first half of 2027 and the answer addressed philosophy. Investment that improves long-term returns is the right call; investment that is not bounded in time is an open-ended claim on the margin line.

Customer Readiness to Take Delivery Against Power and Site Constraints

With the second half requiring the year's fastest conversion, one line of questioning turned to whether customers can physically accept the equipment, citing the widely reported pattern of data center projects slipping on grid interconnection timing. The response invoked an explicit allowance built into the guide rather than a claim that nothing will slip.

Q: "clearly, you're expecting a ramp -- how confident are you in customer ability to take delivery, specifically for data center products? I'm asking because is that narrative out there the projects are getting delayed, power is taking longer to connect."
— Varun Govindaraj, Bernstein

A: "Look, we have a lot of confidence in the backlog. And as we think about our guide, we always assume some level of leakage breakage in the guide, right? We know not everything goes perfectly. We do a great job with our suppliers, but we're also making sure that we've got a little bit of breakage in there. So could there be some things in shift? It is just part of site construction and otherwise, but I'd say that we're confident in our guide."
— Christopher Kuehn, EVP and CFO

Assessment: Disclosing that the guide carries an explicit slippage allowance is more useful than asserting that nothing will slip, and it is consistent with a company that has cleared its guide seventeen quarters running. The allowance was not sized, which leaves the cushion unquantified in the guide that most needs one.

Residential Replacement Versus New Construction, and Competitor Pricing

Residential drew a question framed against a peer that had reported the day before and described difficult pricing and business it was declining to take. Management separated its own exposure, reaffirmed a replacement-weighted mix, and used the answer to walk through the three successive upward revisions to the residential outlook.

Q: "Is there any way to bifurcate how the replacement market did versus resi new construction? And the reason I'm asking is you had a peer report yesterday, who was calling for pretty tough pricing in that market and walking away from some business."
— Joseph Ritchie, Goldman Sachs

A: "I think there's -- we've -- year-to-date, our resi business from a from a dollar basis is up mid-single digits, and we're projecting that to carry forward for the rest of the year. And if you remember, when we came into the year, we thought that residential could be even down a bit this year. And then at the end of the first quarter, we revised it to flat. Now we're very confident with our guide that this will be a mid-single-digit growth number for us."
— David Regnery, Chair and CEO

Assessment: Management answered the outlook question and did not answer the bifurcation question, offering only that residential new construction is in the teens as a share of the business and skewed toward custom builders. Given a peer flagging price pressure in the same market on the same week, the absence of a replacement-versus-new-construction split is a gap. The three-step revision is nonetheless real and the cleanest evidence in the print that the portfolio has broadened.

Sizing and Containing the Middle East Impact

A follow-up sought detail on the EMEA cost actions and whether segment margins can inflect while the regional revenue hole persists. The response is the most complete quantification of a discrete headwind management provided all call.

Q: "maybe you could elaborate on the cost actions you took there and the ability to sort of inflect even if the Middle East is still a bit weak in terms of EMEA margins in the second half."
— Andrew Kaplowitz, Citigroup

A: "I mean just to step back, the Middle East is less than 3% of our total enterprise revenue. But when you look at the EMEA segment, it represents almost about 15% of that segment. So that's why we wanted to make sure we called out that excluding the Middle East, the segment had strong bookings in the quarter, up mid-teens and then revenues were positive, up low single digits."
— Christopher Kuehn, EVP and CFO

Assessment: Sizing the exposure at both the enterprise and segment level, then giving the ex-item performance, is the disclosure standard we asked for in April when the EMEA bookings decline went unexplained. The exchange converts EMEA from an unbounded worry into a bounded, cost-actioned drag with a known revenue assumption attached.

What They're NOT Saying

1. Gross margin, as a line: The 203bp decline was never addressed. Management discussed profitability exclusively at the operating and EBITDA levels, where the declines are 60bps and 70bps, and no analyst asked about the gross line either. Two consecutive quarters of widening gross margin decline in a company guiding to full-year margin expansion is the most conspicuous unexamined item in the print.
2. The dollar size of the price/cost gap: Still refused, for a second consecutive quarter. Management confirmed the direction, confirmed it persists through the second half, and described the sequential path, but has now declined twice to quantify the largest single variable in its own margin bridge.
3. Any sizing of the data center vertical: Unchanged from April. Data centers are still not disclosed as a percentage of revenue, of bookings, or of the $12.1 billion backlog, despite being the acknowledged driver of a fourth consecutive quarter of applied bookings growth above 100%.
4. The composition of the $1.28 billion accrued-expense build: Accrued expenses and other current liabilities rose 37% in six months, and that build is a substantial part of why free cash flow nearly doubled. The earnings exhibit does not disclose what is in it, and nobody asked. If it is customer advances against the applied backlog, the cash flow strength is a timing benefit that unwinds on shipment rather than a durable improvement.
5. Q2 transport refrigeration revenue: Management made a confident forward call on a multi-year transport up cycle and cited three freight indicators supporting it, but did not disclose what Thermo King actually did in the quarter. The segment structure is geographic, so transport is invisible inside the Americas line. The turn is asserted and not yet evidenced in a reported number.
6. The size of the guide's "breakage" allowance: Management disclosed that the guide carries a built-in allowance for project slippage, which is genuinely useful, and then did not size it. In a second-half guide requiring the year's highest organic growth rate in its final quarter, the size of the cushion is the question.
7. Backlog cancellation and deposit terms: Unchanged from April, and now more material. No cancellation rate, deposit structure or termination provision has been disclosed for an order book that has grown 70% and now contains individual orders above $100 million.
8. How far the reinvestment drag extends: Asked directly about the first half of 2027 and answered philosophically. The company will not say when the leverage drag from capacity, integration and channel investment ends.

Market Reaction

• Pre-print setup: TT closed at $446.80 on July 29, up 14.8% year to date against the S&P 500's 6.9%, but up only 3.6% over the trailing twelve months and down 9.0% over the trailing thirty days. The 52-week closing range entering the print was $376.43 to $503.46, so the stock came into the quarter 11.2% below its highest close of the past year. This is the opposite of the April setup, when the stock entered the print up 15.0% in thirty days and within 1.5% of its high.
• Reaction session (July 30, before-open reporter): Opened at $467.91, a 4.7% gap, traded a range of $439.82 to $467.91, and closed at $440.28, down 1.5% or $6.52. The close was 5.9% below the session high and within $0.46 of the session low.
• Volume: 3.2 million shares against a 1.2 million 30-day average, roughly 2.6 times normal.
• Relative performance: The S&P 500 rose 1.7% on the same session, so TT underperformed the index by roughly 3.2 points.

The intraday path is the whole story and it is close to a mirror image of April's. In April the stock gapped up 2.5%, traded as high as 5.0% and closed up 2.7%: buyers paid for the order book and stopped short of paying for conversion. Here the stock gapped up 4.7% on the press release, then surrendered the entire gain and more during and after the call, closing at the bottom of its range. The pre-release premarket was actually slightly negative. What moved the stock up was the eight-thirty headline of a beat and a large raise; what moved it back down was the two hours that followed.

The mechanical explanation is that the call added three pieces of information the release did not contain: that price versus inflation stays a headwind through the second half, that operating leverage came in below the 25% target with no bounded end date for the reinvestment drag, and that the Q4 implied growth rates are the highest of the year. A market that had already marked the stock down 9% in thirty days on margin and data center spending concerns did not need much to sell a 4.7% gap.

The more interesting question is what the 2.6 times volume represents. In April, 1.7 times volume into a new closing high was accumulation that stalled. Here, 2.6 times volume into a close at the session low, following a 9% thirty-day drawdown, is distribution into a beat-and-raise. That is a genuinely negative tape signal and we do not dismiss it. It is also what a de-rating looks like: the forward multiple went from 33.2x on the April print to 28.9x here, while the full-year earnings estimate the multiple is applied to went up $0.40. The market is repricing the multiple, not the earnings, and it is doing so at the exact moment the operational evidence improved. That combination is what changes our rating rather than what confirms it.

Street Perspective

Debate: Does Converting at 40% Settle the Backlog Question?

Bull view: Applied revenue up more than 40% with a management commitment to hold that rate through the second half converts the backlog from a promise into a rate. Add roughly $6 billion scheduled for 2027 and beyond and the visibility into next year is better than at any point in this company's history, which is worth a premium multiple regardless of a single quarter's margin.

Bear view: Half the backlog sits outside the guide year, which means the market is being asked to pay a 2026 multiple for 2028 revenue. The second half needs 11.6% organic growth after 6.3% in the first half, and the fourth quarter alone needs roughly 13%, the highest rate of the year, in the quarter with the least time left to fix a shortfall.

Our take: The bull has the better of this now, which is a change from April. The 40% applied conversion rate is an observed fact rather than an assumption, and management chose to be graded on sustaining it. The bear's timing point stands and is correctly priced into a lower multiple, not into a lower earnings number. The genuine risk in the second half is not whether the backlog converts but whether it converts profitably, which is a different debate.

Debate: Is the Margin Guide Achievable or Aspirational?

Bull view: The first-half margin decline is investment and comparison, not deterioration. SG&A leverage of 104bps proves cost discipline is intact, the prior-year second quarter carried roughly 40% organic leverage that will not repeat as a comparison, and the EMEA cost actions are complete. Fifty basis points in Q3 and a point in Q4 are ordinary outcomes once the comparison normalizes and the volume ramp absorbs fixed cost.

Bear view: Gross margin has now declined for two consecutive quarters and the decline is accelerating, from 100bps to 203bps. Management confirmed price versus inflation stays negative through the second half and will not size it. A company that missed a leverage commitment made ninety days ago is now asking for credit on a bigger one made today, in the same quarter it withdrew Stellar's accretion.

Our take: The bear has the better of this one and it is the reason this upgrade carries a named falsifier rather than a full-throated endorsement. The path to Q3's 50bps runs through volume absorption and mix, not through price catching cost, because management has said price will not catch cost this year. That is achievable on a 10% organic revenue quarter and it is not comfortable. If Q3 delivers flat-to-down margins instead of the guided 50bps of expansion, the second-half EPS bridge breaks at exactly the point where there is no time left to repair it.

Debate: Has the Growth Actually Broadened, or Just the Disclosure?

Bull view: All fourteen tracked verticals grew orders more than 20% in the quarter and eleven of fourteen grew orders year to date, most at double-digit rates. Residential inflected to low-teens organic growth and was raised for a second consecutive time, from a January plan of down roughly 5% to mid-single-digit growth. EMEA organic bookings returned to growth and the European pipeline is inflecting. Asia Pacific booked 31% organic growth. The single-vertical concentration fear is empirically weaker than it was.

Bear view: The backlog is 90% to 95% commercial HVAC and the Americas commercial HVAC book-to-bill is near 135%, so whatever the vertical breadth of the order intake, the balance sheet exposure is one product family in one region. Four orders above $100 million in a single quarter means the growth rate now depends on a small number of very large decisions.

Our take: Both are describing different things and both are right. Vertical breadth genuinely improved and the residential and EMEA turns are real, which weakens the narrow-growth bear case we scored Confirmed in April. Product and regional concentration is unchanged and, if anything, higher. The correct conclusion is that revenue diversification improved while backlog concentration did not, so the near-term earnings stream is safer than it was and the multi-year one is not.

Debate: Valuation at 28.9x After a Four-Turn De-Rating

Bull view: The stock has de-rated from 33.2x to 28.9x on the guide midpoint while that midpoint went up $0.40, and it sits 12.5% below its 52-week closing high after a 9% thirty-day drawdown. The business is measurably better than it was three months ago on every operational axis except gross margin. Paying 28.9x for a company compounding earnings in the mid-teens with 70% backlog growth and record forward visibility is a reasonable entry.

Bear view: Twenty-nine times forward is not cheap in absolute terms for an industrial, and the market has now demonstrated twice in three months that it will sell this stock on a beat-and-raise. Selling 2.6 times normal volume into a close at the session low, after the stock was already down 9% in thirty days, is not sector rotation but a considered opinion about the margin trajectory.

Our take: The bull has the better of it, narrowly, and the reason is the direction of travel rather than the absolute level. In April the multiple was expanding into a quarter with 3% organic growth. Here the multiple is contracting into a quarter with 9% organic growth, a $0.40 raise and a proven conversion rate. Twenty-nine times is the multiple the market itself paid on our forward estimate three months ago, so assuming a return to it is not an assumption of enthusiasm, only of the absence of further de-rating. The tape signal is a genuine caution and it is why we size the bear case at a 23x multiple rather than the 26x we used in April.

Model Framework & Valuation

The table below updates the assumptions we set at initiation against management's raised guidance, and flags where we sit differently.

Valuation. At the July 30 close of $440.28, TT trades at 28.9 times the midpoint of the raised FY26 adjusted EPS guide of $15.25, and at 25.2 times our FY27 estimate of $17.50. That compares with 33.2 times the guide midpoint at the April 30 close of $492.54. The dividend of $4.20 per share annualized yields 0.95%. On the quarter's diluted share count of 222.5 million, the equity is capitalized at roughly $98.0 billion against net debt of approximately $3.3 billion.

Twelve-month value: $508, implying +15.4% from the reaction-day close, plus a 0.95% dividend yield.

The base-case multiple is not an assumption of enthusiasm. Twenty-nine times is approximately what the market paid on our forward estimate three months ago, so the base case requires only that the de-rating stops, not that it reverses. The bull case requires the guided second-half margin cadence to land in full and the 2027 backlog to convert at the applied rates now being demonstrated, sustaining a multiple below where the stock traded on the April print. The bear case requires the Q3 margin expansion to miss, which would push FY27 growth into the low double digits and, on the evidence of this reaction session, would compress the multiple toward the low twenties where the stock traded for most of the prior cycle.

The asymmetry has inverted since April. At initiation we saw roughly six points of upside against fifteen points of downside, which is what set the Hold. Here we see roughly fifteen points of upside against thirteen of downside, with a bull tail worth thirty-four. That change is driven by a 10.6% lower share price against a $0.40 higher earnings base, and it is the arithmetic behind the rating action.

Thesis Scorecard

The table grades the standing thesis established at initiation, unchanged in its pillars, against what this quarter's print and call revealed.

Status tag movements this quarter: Bull #4 moves from AT RISK to ON TRACK on the conversion evidence. Bull #3 moves from ON TRACK to a watch footing, not because anything broke but because the tariff-moat argument went unexamined for a full quarter while the gross margin it was supposed to defend deteriorated further. Bear #1 moves from MATERIALIZING to CONTAINED on vertical, regional and residential breadth. Bear #3 moves from MATERIALIZING to CONTAINED on the four-turn de-rating. Bear #4 moves from CONTAINED to a lower weighting on 37% organic bookings growth. Bear #2 is the one tag that moves the wrong way, from EMERGING to MATERIALIZING, on a gross margin decline that doubled.

Overall: Thesis strengthened. Three of the four bear points weakened materially and the fourth strengthened; both demand pillars were confirmed and the conversion pillar moved from unproven to demonstrated. The three specific signposts we named in April for the demand and guidance side all cleared, and the one we named for margins failed.

Action: Upgrade to Outperform. The specific signposts we will grade at Q3: whether adjusted operating margin expands the guided ~50bps, whether the gross margin decline finally narrows, whether applied revenue growth holds near 40%, and whether the buyback accelerates now that the shares sit 12.5% below their 52-week closing high.

Bottom Line

In April we wrote that Trane had produced the best demand quarter in its history and raised the year by exactly the size of that quarter, and that backlog conversion rather than order intake was the variable that mattered. This quarter converted. Organic revenue nearly tripled its growth rate to 9% against a 5% guide, applied revenue grew more than 40% with that rate committed for the second half, and the full-year EPS guide moved $0.40 on a $0.05 beat while separately absorbing a newly quantified $0.10 Middle East headwind. Backlog reached $12.1 billion, up 70%, with the 2027 split finally disclosed. Vertical, regional and residential breadth all improved. Three of the four questions we said we would grade this quarter were answered in the affirmative.

The fourth was not. Gross margin fell 203bps against a 100bp decline last quarter, operating leverage came in below a commitment made ninety days earlier, and Stellar's accretion was withdrawn. The market saw the same thing: it bought the release, sold the call, and closed the stock down 1.5% at the session low on 2.6 times volume after a 4.7% opening gap. Those are not the actions of a market that believes the margin guide.

We upgrade anyway, because the price has moved further than the doubt. The stock is 10.6% below where it traded on the April print while the earnings it is valued against are $0.40 higher, which takes the forward multiple from 33.2x to 28.9x and inverts the risk/reward from roughly six points of upside against fifteen of downside to roughly fifteen against thirteen. Owning a franchise of this quality at the multiple the market itself paid three months ago, on a demonstrably better order book and a demonstrably proven conversion rate, is a better trade than waiting for a cheaper price that a 70% backlog build makes progressively less likely.

We upgrade to Outperform with a twelve-month value of $508. We would move back to Hold if Q3 fails to deliver the guided ~50bps of adjusted operating margin expansion, or if applied revenue growth decelerates below 30% while the backlog keeps building. We would move to Underperform if a fourth-quarter organic shortfall forces the full-year guide down, since the multiple has already shown it will not absorb one.